Assessing the Role of Adalimumab in Treating Hidradenitis Suppurativa: Findings from a Retrospective Study at a Reference Center.
Austėja ŠakaitytėInga ČesnavičiūtėTadas RaudonisPublished in: Clinics and practice (2024)
About half of HS patients responded positively to adalimumab treatment; the use of the drug reduces inflammatory lesions, and pain, and improves quality of life.
Keyphrases